CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- 4 Open-market sale Director sold 6,000 shares at an average $42.60 ($255,570)
- 4 Open-market sale SVP, Clinical Dev, Drug Safety sold 2,873 shares at $45.00 ($129,285)
- 4 Open-market sale Chief Executive Officer sold 39,636 shares at an average $44.20 ($1,752,006)
- 4 Exercise or conversion SVP, Clinical Dev, Drug Safety acquired 16,000 shares (option exercise)
- 4 Open-market sale SVP, Finance and CFO sold 3,201 shares at $43.12 ($138,027)
- 4 Open-market sale SVP, China Operations sold 11,250 shares at an average $44.05 ($495,563)
- 4 Open-market sale Chief Medical Officer sold 3,420 shares at $40.96 ($140,083)
- 4 Grant or award Director acquired 4,648 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,360 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 39,636 shares at an average $38.21 ($1,514,452)
- 4 Shares withheld for taxes SVP, Clinical Dev, Drug Safety gave up 2,058 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Finance and CFO gave up 3,144 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, China Operations gave up 3,480 shares (to pay taxes)
- 4 Grant or award Director acquired 4,700 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 38 · 760 filings